(Q28263158)

27 March 2017

1 reference

Robert G Salomon

1

0 references

ROBERT G. SALOMON

series ordinal

1

1 reference

27 March 2017

language of work or name

English

0 references

publication date

June 2005

1 reference

Annals of the New York Academy of Sciences

27 March 2017

published in

1 reference

27 March 2017

volume

1043

1 reference

27 March 2017

issue

1

1 reference

27 March 2017

page(s)

327-42

0 references

327-342

1 reference

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Levuglandin E2 inhibits mitosis and microtubule assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Levuglandin E2-protein adducts in human plasma and vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Animal longevity and protein turnover rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Extraction and partial characterization of dialysable products originating from the peroxidation of liver microsomal lipids and inhibiting microsomal glucose 6-phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Oxidative fragmentation of hydroxy octadecadienoates generates biologically active gamma-hydroxyalkenals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.040

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1333.040

1 reference